Suppr超能文献

在同基因结肠癌细胞中鉴定抗转移药物和天然化合物靶点。

Identification of anti-metastatic drug and natural compound targets in isogenic colorectal cancer cells.

作者信息

Lee Jin-Gyun, McKinney Kimberly Q, Pavlopoulos Antonis J, Park Jeong-Hill, Hwang Sunil

机构信息

Proteomics Laboratory for Clinical and Translational Research, Carolinas HealthCare System, Charlotte, NC 28203, United States.

College of Pharmacy, Seoul National University, Seoul 151-742, South Korea.

出版信息

J Proteomics. 2015 Jan 15;113:326-36. doi: 10.1016/j.jprot.2014.10.009. Epub 2014 Oct 23.

Abstract

UNLABELLED

Therapeutic strategies for cancer treatment often remain challenging due to the cumulative risk derived from metastasis, which has been described as an aggressive state of cancer cell proliferation often resulting in failure of clinical therapy. In the current study, anti-metastatic properties of three chemotherapeutic drugs and three compounds from natural sources were investigated by comparative proteomic analysis. Proteomic profile comparison of the isogenic primary and metastatic colon cancer cell lines SW480 and SW620 identified two potential metastasis related molecular targets: fatty acid synthase and histone H4. To demonstrate their biological roles in cancer metastasis, the expression of these target genes was suppressed by siRNA transfection. Subsequent cell migration assays demonstrated reduced migratory effects. SW620 cells were treated with six anti-cancerous components. Through comprehensive proteomic analysis, three of the tested compounds, oxaliplatin, ginsenoside 20(S)-Rg3 and curcumin, were revealed to have a suppressive effect on FASN and histone H4 expression. SW620 cells treated with these drugs showed significantly reduced migratory activity, which suggests that drug-induced targeted suppression of these genes may affect cell migration. The validity of the proteomic datasets was verified by knowledgebase pathway analysis and immunoblotting assays. The anti-metastatic components revealed by the current proteomic analysis represent promising chemotherapeutic candidates for the treatment of colorectal adenocarcinoma.

BIOLOGICAL SIGNIFICANCE

The current study demonstrates anti-metastatic activity of chemotherapeutics and natural components by the suppression of target molecules, fatty acid synthase and histone H4 identified by a comparative proteomic analysis employing the isogenic primary and metastatic colon cancer cell lines, SW480 and SW620. Three tested drugs, namely, oxaliplatin, ginsenoside 20(S)-Rg3 and curcumin were revealed to possess suppressive effects on fatty acid synthase and histone H4 and reduce metastasis as determined by cell migration assay. Data were confirmed by the correlation between spectral counts from proteomic data and Western blot analysis, which were in good agreement with immunohistochemistry.

摘要

未标记

癌症治疗的策略往往仍具有挑战性,因为转移带来的累积风险,转移被描述为癌细胞增殖的一种侵袭性状态,常常导致临床治疗失败。在当前研究中,通过比较蛋白质组学分析研究了三种化疗药物和三种天然来源化合物的抗转移特性。对同基因原发性和转移性结肠癌细胞系SW480和SW620进行蛋白质组谱比较,确定了两个潜在的转移相关分子靶点:脂肪酸合酶和组蛋白H4。为了证明它们在癌症转移中的生物学作用,通过小干扰RNA转染抑制这些靶基因的表达。随后的细胞迁移试验表明迁移作用降低。用六种抗癌成分处理SW620细胞。通过全面的蛋白质组学分析,发现所测试的三种化合物,即奥沙利铂、人参皂苷20(S)-Rg3和姜黄素,对脂肪酸合酶和组蛋白H4的表达有抑制作用。用这些药物处理的SW620细胞显示迁移活性显著降低,这表明药物诱导的这些基因的靶向抑制可能影响细胞迁移。通过知识库通路分析和免疫印迹试验验证了蛋白质组数据集的有效性。当前蛋白质组分析揭示的抗转移成分代表了用于治疗结直肠癌的有前景的化疗候选药物。

生物学意义

当前研究通过抑制脂肪酸合酶和组蛋白H4这两个通过使用同基因原发性和转移性结肠癌细胞系SW480和SW620的比较蛋白质组分析确定的靶分子,证明了化疗药物和天然成分的抗转移活性。通过细胞迁移试验确定,所测试的三种药物,即奥沙利铂、人参皂苷20(S)-Rg3和姜黄素,对脂肪酸合酶和组蛋白H4具有抑制作用并减少转移。蛋白质组数据的光谱计数与蛋白质印迹分析之间的相关性证实了数据,这与免疫组织化学结果高度一致。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验